• Volume 12,Issue 08,2013 Table of Contents
    Select All
    Display Type: |
    • >Brief Introduction of Expert Soliciting Special Topic
    • Brief Introduction of Expert Soliciting Special Topic

      2013, 12(08):0-0.

      Abstract (1618) HTML (0) PDF 175.17 K (1795) Comment (0) Favorites

      Abstract:

    • >Contents
    • Chinese language

      2013, 12(08):1-2.

      Abstract (1584) HTML (0) PDF 200.82 K (1739) Comment (0) Favorites

      Abstract:

    • English language

      2013, 12(08):3-4.

      Abstract (1746) HTML (0) PDF 31.28 K (1790) Comment (0) Favorites

      Abstract:

    • >Editorial
    • On therapy of acute myelogenous leukemia therapy in the elderly

      2013, 12(08):561-564. DOI: 10.3724/SP.J.1264.2013.00141

      Abstract (1984) HTML (0) PDF 324.63 K (2451) Comment (0) Favorites

      Abstract:The incidence of acute myelogenous leukemia (AML) increases with aging. Due to the low complete remission rate and high treatment-related mortality and the poor prognosis, there is lack of unified and effective therapeutic strategies for elderly patients with AML. In this paper, we reviewed the current situation on treatment of AML in the elderly, including the roles of conventional chemotherapy, allogeneic stem cell transplantation and some novel targeted agents.

    • >Special Topic
    • Acute leukemia in the elderly: clinical analysis of 340 cases

      2013, 12(08):565-569. DOI: 10.3724/SP.J.1264.2013.00142

      Abstract (1650) HTML (0) PDF 467.43 K (3030) Comment (0) Favorites

      Abstract:Objective To investigate the distribution and prognosis of elderly patients with acute leukemia. Methods Clinical data of 340 untreated acute leukemia patients with age over 60 years admitted in our hospital from September 2009 to May 2013 were enrolled in this study. Their onset age, prognostic risk factors, therapy and survival were retrospectively analyzed. Results In this cohort of patients, their median onset age was 68 years. There were 24 patients (7.06%) with acute lymphoblastic leukemia (ALL). In 314 patients with acute myeloblastic leukemia (AML), there were 250 patients (79.62%) with de novo AML, and 9 patients with acute promyelocytic leukemia (APL). There were 34 cases (14.11%) of de novo AML (non APL) having good prognosis based on cytogenetic and molecular biology, and 61 cases having unfavourable prognosis. The proportion of good prognosis was decreased along with the increase of age, while that of unfavourable prognosis was elevated. Among the 93 patients with survival data, 85 of them received chemotherapy. Age also exerted obvious effect on the complete remission (CR) rate and total survival rate. Patients who gained CR after chemotherapy had longer survival than those without CR. Conclusion The prognosis of elderly patients with acute leukemia is poor. How to improve the total survival rate is still a difficult task.

    • Morphology, immunophenotypes, cytogenetics and molecular biology of Waldenstrom macroglobulinemia

      2013, 12(08):570-574. DOI: 10.3724/SP.J.1264.2013.00143

      Abstract (2168) HTML (0) PDF 418.04 K (2200) Comment (0) Favorites

      Abstract:Objective To analyze the morphology, immunophenotypes, cytogenetics and molecular biology (MICM) abnomaities of Waldenstrom macroglobulinemia (WM). Methods Clinical data of 41 patients with newly diagnosed WM from 1999 to 2010 were collected and studied retrospectively (including 27 males and 14 females). Their clinical manifestations, cell morphology in bone marrow, immunophenotypes, and cytogenetics, immunoglobulin heavy chain gene rearrangement, and expression of preferentially expressed antigen of melanoma (PRAME) were examined by G-banding and FISH, PCR-IgH and RQ-PCR-PRAME and MAGE C1/CT7, and the results were analyzed with clinical prognosis. Results The incidence of high risk patients accounted for 58.5%. Their imunnophenotypes was 100.0% positive to CD19, 97.6% positive to CD20, 74.1% positive to CD38, 36.9% positive to FMC7, 10.0% positive to CD5, 31.6% positive to CD23, 83.3% positive to HLA-DR, and 85.7% positive to CXCR4. There were specific cytogenetic abnormalities found by G-Banding and FISH. RQ-PCR-PRAME had high quantities in WM, which was related to the number of lymphocyte in bone marrow. The MAGE C1/CT7 was negatively expressed in WM. There was no significant survival difference between the Rituximab containing regimen and COP (cyclophosphamide combined with vindisine and prednisone) in treatment of WM. Conclusion WM has specific MICM characteristics. Integrating those measures is helpful to diagnose WM as early as possible, and to monitor the disease during the treatment. Rituximab has no survival benefit in this cohort of patients.

    • Clinical characteristics of nodal marginal zone lymphoma

      2013, 12(08):575-580. DOI: 10.3724/SP.J.1264.2013.00144

      Abstract (2218) HTML (0) PDF 389.38 K (2230) Comment (0) Favorites

      Abstract:Objective To investigate the clinical characteristics of nodal marginal zone lymphoma (NMZL). Methods Data of 14 NMZL patients diagnosed by lymph nodes histological examination were retrospectively analyzed. Results Among the 14 patients, 13(92.9%) had abnormal complete blood counts(CBC). Leukocytosis [white blood cells(WBC)≥10.0×109/L] was observed in 6 patients (42.9%); leukocytopenia (WBC<4.0×109/L) in 4 patients(28.6%); absolute lymphocyte counts>5.0×109/L in 7 patients (50%); hemoglobin concentration<120g/L in 10 patients(71.4%), thrombocytopenia(platelet<100×109/L) in 6 patients(42.9%); cytopenia in more than 2 lineages in 4 patients (28.6%); pancytopenia in 2 cases(14.3%). Ten patients(71.4%) had bone marrow involvement. Among them, monoclonal B cells with a light chain restriction was found in 5 patients (50%). Percentage of lymphocytes in peripheral blood correlated positively with percentage of NMZL cells in bone marrow(r=0.811,P=0.008). Hyperimmunoglobulinemia was found in all patients (12/12, 100%). Among them, serum monoclonal paraprotein was found in 10 patients(10/12, 83.3%). At least one auto-antibody positivity was found in 8 out of 11 patients (72.7%). All of 14 patients had Ann Arbor stage Ⅲ or Ⅳ. Immunochemotherapy was administered in 10 patients. Rituximab was given as a single agent to 1 patient. Chemotherapy was given to 2 patients, and interferon alpha was given to 1 patient. Complete response was achieved in 8 patients (57.1%), and partial response in 3 patients (21.4%). Median duration of follow-up was 23 months. Accumulated 2-year overall survival (OS) rate and 2-year progression-free survival (PFS) rate were 84.6% and 71.4%, respectively. Estimated median OS and PFS were 90 and 39 months, respectively. Conclusion NMZL patients at stage Ⅲ/Ⅳ have high a incidence of CBC abnormality, bone marrow involvement and autoimmunologic abnormality. Peripheral blood lymphocytosis might indicate NMZL bone marrow involvement.

    • Clinical and prognostic features of acute promyelocytic leukemia in the elderly

      2013, 12(08):581-584. DOI: 10.3724/SP.J.1264.2013.00145

      Abstract (2273) HTML (0) PDF 327.42 K (1918) Comment (0) Favorites

      Abstract:Objective To compare the clinical manifestations, response to treatment and long-term survival of acute promyelocytic leukemia(APL) between elderly and young patients, and to determine the efficacy and safety of the all-trans retinoic acid combining arsenic trioxide and chemotherapy for the elderly. Methods Clinical data of 247 patients with APL admitted in our institute from 1992 to 2010 were collected, and retrospectively studied to compare their clinical manifestations, remission, relapse, mortality and survival rate between elderly (with an age of ≥55, n=21) and non-elderly groups (with an age of <55, n=226). Results (1) There was no significant difference between the elderly and non-elderly APL patients in gender, white blood cells, hemoglobin, platelets, disseminated intravascular coagulation (DIC), central nervous system leukemia (CNSL), and immunophenotypes of CD56 and CD117. (2) The rate of complete remission (CR) (100.0% vs 95.1%) and mortality in induction therapy (0.0% vs 4.4%) were a little bit better in the elderly group than the non-elderly group, though without significant difference (P=0.301, P=0.325). But the relapse rate (19.0% vs 16.3%) and death in CR (4.8% vs 1.9%) were higher in elderly APL than in non-elderly group, and there was no significant difference either between them (P=0.744, P=0.095). (3) No obvious difference was found in 4-year, 6-year, and 7-year overall survival rate and event-free survival rates between elderly and non-elderly APL (P>0.05). Conclusions There is no significant difference between the elderly and non-elderly APL in clinical features, response to treatment and long-term survival. So, the efficacy and safety of current treatment are guaranteed for elderly APL patients.

    • Chronic myelomonocytic leukemia in the elderly: 21 cases report

      2013, 12(08):585-586. DOI: 10.3724/SP.J.1264.2013.00146

      Abstract (1811) HTML (0) PDF 314.92 K (4341) Comment (0) Favorites

      Abstract:

    • Allogeneic hematopoietic stem cell transplantation for chronic lymphocytic leukemia

      2013, 12(08):587-593. DOI: 10.3724/SP.J.1264.2013.00147

      Abstract (1949) HTML (0) PDF 371.90 K (2101) Comment (0) Favorites

      Abstract:Chronic lymphocytic leukemia(CLL) is an indolent lymphoproliferative disorder with great clinical heterogeneity. The immunochemotherapeutic regimens have improved the outcome of majority of the patients. Nonetheless, in some patients, the disease progresses shortly after the immunochemotherapy, while in others, it becomes refractory and drug resistant. Allogeneic hematopoietic stem cell transplantation(allo-SCT) potentially cures CLL due to the graft versus CLL effect. It has been wildly accepted that allo-SCT is a good option for young CLL patients with high risk factors, including purine analogue resistance, early relapse after purine analogue-based treatment, and 17p deletion and TP53 mutation. Reduced-intensity conditioning regimens effectively decrease the treatment-related mortality.

    • >Clinical Research
    • Role of inflammatory factor CD40 ligand in patients with acute coronary syndrome

      2013, 12(08):594-597. DOI: 10.3724/SP.J.1264.2013.00148

      Abstract (1957) HTML (0) PDF 498.98 K (2060) Comment (0) Favorites

      Abstract:Objective To determine the serum levels of soluble CD40 ligand (sCD40L) and high sensitivity C-reaction protein (hs-CRP) in patients with acute coronary syndrome (ACS) and their clinical significance. Methods A total of 116 ACS inpatients [86 males and 30 females; aged (58.4±10.4)years, ranging from 39 to 78 years] in the Department of Cardiology of Xijing Hospital from May to December 2011 were enrolled in this study. There were 88 cases of unstable angina and 28 cases of acute myocardial infarction. Another 21 patients with normal coronary angiography served as control group (n=21). Fasting forearm venous blood samples were taken from all patients in the morning for the serum levels of sCD40L and hs-CRP by enzyme-linked immunosorbent assay (ELISA). All patients underwent coronary angiography within 2 to 4 d after admission for the extent of coronary artery stenosis, which were further analyzed with the Gensini scoring system. Results The serum levels of hs-CRP and sCD40L were obviously higher in ACS group than in the controls (P<0.05). The serum levels of sCD40L and hs-CRP were positively correlated with the Gensini score respectively (r=0.328, P=0.000; r=0.748, P=0.000). Positive correlation was also found between sCD40l and hs-CRP levels (r=0.192, P=0.039). Conclusion The serum levels of sCD40L and hs-CRP are obviously increased in ACS patients, suggesting that CD40/CD40L system may be involved in the development of ACS.

    • Treatment compliance and metabolic control in type 2 diabetic patients: a retrospective analysis of 6330 cases

      2013, 12(08):598-601. DOI: 10.3724/SP.J.1264.2013.00149

      Abstract (2120) HTML (0) PDF 345.49 K (2356) Comment (0) Favorites

      Abstract:Objective To acquaint the treatment compliance and the changes of body mass, blood glucose, blood pressure and blood lipids and other metabolic indices in the Chinese patients with type 2 diabetes from 1994 to 2009 in order to provide theoretical basis for the management of diabetic patients. Methods Retrospective analysis was carried out on 6330 patients with type 2 diabetes (3085 males and 3245 females). The patients were divided into three groups according to the date of their visiting diabetes center: group 1 (from 1994 to 1999), group 2 (from 2000 to 2004), and group 3 (from 2005 to 2009). Results There were 1253 (19.79%), 1865 (29.46%) and 3212 (50.75%) patients in the three groups, respectively. With the elapse of time, their compliance to oral anti-diabetic agents was obviously improved, and the percentage of the patients taking insulin therapy was increased, and their fasting blood glucose, 2-hour post-prandial blood glucose, HbA1c, and blood pressure were obviously decreased, and total cholesterol was slightly decreased, but body mass index, waist circumference and triglyceride were increased. Totally there were 16.9%, 13.2% and 25.7% patients respectively getting normal fasting blood glucose, 2-hour post-prandial blood glucose and HbA1c. Conclusion In recent 10 years, most Chinese patients with type 2 diabetes have got better control in blood glucose and blood pressure, but their metabolic control is not satisfactory enough. The key point for diabetic management is to strengthen education and intervention, and to pay more attention to self-control and behavior management in the patients.

    • Levosimendan vs epinephrine in treatment of low cardiac output after cardiac surgery

      2013, 12(08):602-606. DOI: 10.3724/SP.J.1264.2013.00150

      Abstract (2268) HTML (0) PDF 382.61 K (1943) Comment (0) Favorites

      Abstract:Objective To compare the effects of levosimendan vs epinephrine on low cardiac output syndrome (LCOS) after cardiac surgery. Methods Forty-eight patients with LCOS after cardiac surgery in our department from 2011 to 2012 were enrolled in this prospective study. They were randomly assigned to levosimendan group [n=23, 0.05 to 0.2μg·(kg·min) for 24h] and epinephrine group [n=25, 0.01 to 0.04μg·(kg·min) for 1 week] to maintain the mean arterial pressure ≥65mmHg. Their heart rate, mean arterial pressure, pulmonary artery wedge pressure, central venous pressure, cardiac output, cardiac index, systemic vascular resistance and cardiac function (evaluated by echocardiography before and on 3 and 7d after drug injection, respectively) were monitored as well as blood lactate and kidney function (urea nitrogen, serum creatinine and urine output before and at 24 and 48h after drug injection, respectively). The postoperative complications and prognosis were also observed. Results Cardiac output and cardiac index were significantly increased, but blood lactate was obviously decreased after the drug injection compared with before the injection (P<0.05). Levosimendan injection for 48h resulted in significant changes in urea nitrogen, serum creatinine and urine output (P<0.05), with the first one significantly lower than that of epinephrine group (P<0.05). There was significantly lower incidence of atrial fibrillation in levosimendan group than in epinephrine group (P<0.05). Levosimendan injection also caused a decreasing trend of post-operative complications. Conclusion Both leosimendan and adrenaline obviously improve the hemodynamic indices and cardiac functions, and tissue perfusion in LCOS patients after cardiac surgery. Leosimendan is more beneficial to renal function.

    • Relationship of serum 1,5-anhydroglucitol with mean 24-hour blood glucose and glycemic excursion in aged patients with type 2 diabetes mellitus

      2013, 12(08):607-610. DOI: 10.3724/SP.J.1264.2013.00151

      Abstract (2053) HTML (0) PDF 329.74 K (2379) Comment (0) Favorites

      Abstract:Objective To investigate the relationship of serum level of 1,5-anhydroglucitol (1,5-AG) with mean 24-hour blood glucose and glycemic excursion in the aged patients with type 2 diabetes mellitus (T2DM), and to explore whether serum 1,5-AG can be used as one of the indicators for the clinical observation and treatment of the disease. Methods Totally ninety-five aged T2DM inpatients, 65 males and 30 females, with age ranging from 70 to 80 (80.1±4.3) years, who were admitted in our department from July 2009 to July 2012, were enrolled in this study. They were uniformed for their mealtime, and monitored for blood glucose for 3 consecutive days with a continuous glucose monitoring system (CGMS). Their reference blood glucose, diet, times of taking medicine and doing exercises were recorded. Venous blood sample was collected on the 3rd day for the analysis of 1,5-AG, glycated hemoglobin (HbA1c), and glycosylated serum protein (GSP) after 8 hours fasting. Results The serum level of 1,5-AG was negatively correlated with fasting blood glucose (FBG), 2-hour postprandial blood glucose, HbA1c, GSP, mean blood glucose (MBG) within 3d, and mean amplitude of glycemic excursions (MAGE) (all P<0.05). Pearson correlation analysis indicated that the serum level of 1,5-AG had a negative correlation with MBG at the 6 time points of a day: 1h before breakfast, 2h after breakfast, 3h after breakfast, 2h after dinner, 3h after dinner, and 2∶00 am to 4∶00am (all P<0.05), but the level had no relation with MBG at other time points. Conclusion Serum level of 1,5-AG makes sound reflections of MBG and glycemic excursion within a short period, and can be considered as one of the indicators for diabetic screening and clinical monitoring for treatment.

    • Analysis on clinical data of elderly in-patients with delirium during psychiatric consultation at Chinese general hospitals

      2013, 12(08):611-614. DOI: 10.3724/SP.J.1264.2013.00152

      Abstract (1932) HTML (0) PDF 344.90 K (2048) Comment (0) Favorites

      Abstract:Objective To investigate the clinical features of elderly in-patients with delirium in the psychiatric consultations at general hospitals. Methods A total of 364 elderly in-patients (over 65 years old) from general hospitals who were diagnosed as delirium during the psychiatric consultation by our department during 2008 to 2011 were subjected in this study. Detailed clinical data of all subjects were retrospectively surveyed by self-made questionnaire for consultation reasons, primary physical diseases, and drug treatment after consultation, and then summarized and analyzed. Results The most common reasons for psychiatric consultation were disturbance of consciousness (55.2%) and verbal or behavioral confusion (24.6%). Medical conditions of these subjects were mainly neurological diseases (25.0%), post-operation (24.7%), cardiovascular diseases (22.5%) and respiratory diseases (19.2%). Neuroleptics were administered to 83.5% of the subjects, and they were olanzapine (46.2%), haloperidol (29.7%), quetiapine (5.2%), risperidone (3.8%) and benzodiazepines (3.8%). During the four years, the proportion of olanzapine was increased from 35.3% in 2008 to 56.9% in 2011 (P<0.01), while that of haloperidol was decreased from 38.2% in 2008 to 19.3% in 2011 (P<0.01). Conclusion Elderly in-patients are at high-risk of delirium, especially for those with cerebral infarction, infection or after surgery. More attention should be paid to these elderly patients.

    • Survey on health status and health care demands in senior inhabitants in Taiyanggong and Xiangheyuan communities of Beijing

      2013, 12(08):615-618. DOI: 10.3724/SP.J.1264.2013.00153

      Abstract (1798) HTML (0) PDF 348.98 K (2033) Comment (0) Favorites

      Abstract:Objective To explore the health status and the health care demands in senior inhabitants from the communities of Taiyanggong and Xiangheyuan in Beijing in order to provide information for better services. Methods The community residents who were over 60 years old were surveyed by our self-designed questionnaires when they received free physical examination. Results Most of the participants had moderate self-rated health status (76.5%), and few had poor self-rated health status(7.2%). The prevalence of chronic diseases was 74.6%, while participants with two or more chronic diseases accounted for 38.0%. The elderly had the following health-care demands: health examination (72.4%), health guidance (45.5%), home-visit care (35.2%) and home hospitalization service (21.2%). Those at different ages or with different educational background had different health care demands. Conclusion Chronic disease is the major problem in the two communities. We should strengthen the prevention and control of chronic diseases in the future. The key to meet different demands of the elderly is to organize and provide a demand-oriented, diversified and multi-leveled health service.

    • Clinical significance of serum tumor markers in elderly patients with non-small cell lung cancer

      2013, 12(08):619-624. DOI: 10.3724/SP.J.1264.2013.00154

      Abstract (1808) HTML (0) PDF 376.41 K (2574) Comment (0) Favorites

      Abstract:Objective To investigate the relationship of serum levels of carcinoembryonic antigen (CEA), carbohydrate antigen 199 (CA199), squamous cell carcinoma antigen (SCC-Ag), carbohydrate antigen 125 (CA125) and cytokeratin fragment antigen 21-1 (CYFRA21-1) with different pathological types and stages of non-small cell lung cancer(NSCLC) in elderly patients. Methods A total of 90 patients with age over 65 years and pathologically identified NSCLC hospitalized in our department from August 2009 to December 2012 were subjected in this study. Electrochemiluminescence method was applied to detect the expression of above-mentioned 5 serum tumor markers in these patients. Results The expression levels of the five serum tumor markers were significantly higher in the cohort than in healthy volunteers (P<0.05). But no significant difference was found in the levels between different genders, or among those of different age groups (P>0.05). The levels of CEA, CA199, and CA125 were significantly higher in patients with adenocarcinoma than those of squamous cell cancer (P<0.05), but levels of SCC-Ag and CYFRA21-1 were significantly higher in patients with squamous cell cancer than in those of adenocarcinoma. (P<0.05). The expression of CYFRA21-1 and CA125 was significantly higher in the patients at N2 and N3 stages than those at N0 and N1 stages (P<0.05). Furthermore, serum level of CEA was obviously higher in the patients with distant metastasis than those without (P=0.041). The serum levels of CEA and SCC-Ag were increased along with more metastases the patients had (P<0.05). And the expression of CEA was remarkably higher in those at the stage of Ⅳb than at the stage of Ⅰ, Ⅱ, Ⅲ and Ⅳa (P=0.046). Conclusions Serum tumor markers, CEA, CA199 and CA125 are valuable in the diagnosis of late-stage adenocarcinoma of the lung, and SCC-Ag and CYFRA21-1 are more valuable for the diagnosis of squamous cell carcinoma. There is no correlation of the five tumor markers with gender and age. Serum level of CEA is positively correlated to clinical stages of lung cancer. Namely, high level predicts an advanced stage, but low level contributes little to staging. High levels of CEA and SCC-Ag may indicate multiple metastatic sites.

    • >Basic Research
    • Therapeutic efficiency of Xuebijing on sheep multiple organ dysfunction syndrome at high altitude

      2013, 12(08):625-628. DOI: 10.3724/SP.J.1264.2013.00155

      Abstract (1886) HTML (0) PDF 435.63 K (1876) Comment (0) Favorites

      Abstract:Objective To determine therapeutic effect of Xuebijing (XBJ) injection, a compound injection of traditional Chinese herbs, on multiple organ dysfunction syndrome at high altitude (H-MODS). Methods A total of 18 sheep were randomly divided into control, model and XBJ treatment groups, with 6 sheep in each group. After the sheep quickly reached a highland of 3500m, H-MODS model was inflicted by venous injection of 6μg/kg lipopolysaccharide (LPS), and LPS was substituted with normal saline in the same dose for control group. After that, the sheep in model and XBJ groups were given an intravenous injection of 2ml/kg normal saline and 2ml/kg XBJ injection respectively, twice per day for 3 consecutive days. Biochemical parameters and blood routine indices were detected in the blood samples collected at 0, 3, 12, 24, 48 and 72h after model establishment. Results The contents of creatine kinase (CK), creatine kinase isoenzyme (CK-MB), aspartic transaminase (AST), alanine aminotransferase (ALT), total bilirubin (TBIL) and creatinine (Cr) were significantly higher in the model group than in the control and treatment groups (P<0.05 or P<0.01) at the different time points. Compared with the control, the number of white blood cells (WBC) was obviously decreased rapidly in the model and treatment groups at 3h, and then began to elevate suddenly in another 3h later. But the increasing tendency was more smoothly in the treatment group than in the model group. Conclusion XBJ injection exerts protective effect on the heart, lung, liver, and kidney in sheep against H-MODS injury.

    • Effects of rhBNP on sodium current in isolated ventricular myocytes from ischemia/reperfusion myocardium of rabbit

      2013, 12(08):629-631. DOI: 10.3724/SP.J.1264.2013.00156

      Abstract (1875) HTML (0) PDF 426.34 K (2475) Comment (0) Favorites

      Abstract:Objective To investigate the effects of recombinant human brain natriuretic peptide (rhBNP) on sodium current (INa) in left ventricular myocytes of rabbit heart undergoing ischemia/reperfusion(I/R), so as to explore the cellular (ionic) basis of rhBNP treatment for antiarrhythmia. Methods Forty-five rabbits were randomly divided into three groups (n=15): ischemic/reperfusion (I/R) group, rhBNP intervention (rhBNP) group and sham-operation control (CON) group. Anesthetized rabbits were subjected to 30min ischemia by ligation of the left anterior descending coronary artery and 120min reperfusion. rhBNP group was injected with rhBNP at a dose of 0.06μg/(kg·min) via ear-vein. Single ventricular myocytes were isolated enzymatically from the epicardial zone of the infracted region derived from the hearts in I/R, rhBNP groups and the same anatomy region in CON group. Whole cell patch clamp technique was used to record INa. Results The peak INa density (at –30mV) was significantly decreased in I/R group [(–22.46±5.32)pA/pF, n=12] compared with CON group [(–42.78±5.48)pA/pF, n=16; P<0.01], while it was significantly increased in rhBNP group[(-37.82±5.45)pA/pF, n=15] compared with I/R group(P<0.01). Conclusion Ischemia/reperfusion induces significant down-regulation of INa, and pretreatment with rhBNP could attenuate these changes, prevent and reverse this electrical remodeling.

    • >Short Report
    • Role of tumor specific growth factar detection in diagnosis of malignant tumor in digestive system: 500 cases report

      2013, 12(08):632-632. DOI: 10.3724/SP.J.1264.2013.00157

      Abstract (1648) HTML (0) PDF 247.67 K (2625) Comment (0) Favorites

      Abstract:

    • >Clinicopathological Conference
    • Reverse precise thrombolysis along with stent placement for acute coronary artery occlusion: one case report

      2013, 12(08):633-635. DOI: 10.3724/SP.J.1264.2013.00158

      Abstract (2078) HTML (0) PDF 429.72 K (2077) Comment (0) Favorites

      Abstract:Reperfusion therapy for acute myocardial infarction has the best opportunity to save patient’s life, reduce the early mortality and to improve patient’s life quality. The effective methods used to reintroduce blood flow to an ischemic region of the myocardium currently include intravenous thrombolysis, intracoronary thrombolysis, thrombectomy and intervention which directly catheterizes the infarct-related artery. Up to now, there is no report about reverse thrombolysis for acute coronary artery occlusion. In this paper, we reported a case with satisfactory result, who received reverse precise thrombolysis with urokinase along with stenting. Several critical issues need further investigation, including specific definition criteria of the target vessel thrombosis, standardized manipulation methods, as well as its long-term efficacy.

    • >Review
    • Diagnosis and treatment of hypertension with atherosclerotic renal arterial stenosis

      2013, 12(08):636-640. DOI: 10.3724/SP.J.1264.2013.00159

      Abstract (1959) HTML (0) PDF 365.53 K (2556) Comment (0) Favorites

      Abstract:(Department of Nephrology, People’s Hospital of Peking University, Beijing 100044, China)

Superintendor:Chinese PLA General Hospital

Sponsor:Medical Innovation Research Division, Chinese PLA General Hospital/ National Clinical Research Center for Geriatric Diseases (Chinese PLA General Hospital)/Department of Cardiology, Sixth Medical Center, Chinese PLA General Hospital

Editor-in-Chief:Fan Li

Executive Editor:Chen Yundai

Tel:010-66936756

E-mail: zhlndqg@mode301.cn

ISSN:1671-5403

CN:11-4786/R

Founding Date:2002

Publishing Cycle:Monthly

Postal Code:82-408

  • Most Read
  • Most Cited
  • Most Downloaded
Press search
Search term
From To